Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Linagliptin”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01734785
What this trial is testing

Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 607
Large-scale testing (Phase 3)UnknownNCT04134650
What this trial is testing

Effect of Low Dose Combination of Linagliptin + Metformin to Prevent Diabetes

Who this might be right for
Prediabetic StateInsulin Resistance
Universidad de Guanajuato 34
Early research (Phase 1)Study completedNCT02221414
What this trial is testing

Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 95
Post-approval studies (Phase 4)Study completedNCT02350478
What this trial is testing

Effects of Linagliptin on Endothelial Function

Who this might be right for
Type 2 DiabetesCoronary Artery Disease
Medical University of Graz 49
Large-scale testing (Phase 3)Study completedNCT02489968
What this trial is testing

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 880
Large-scale testing (Phase 3)Study completedNCT02453555
What this trial is testing

Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 275
Post-approval studies (Phase 4)Study completedNCT03011177
What this trial is testing

Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients

Who this might be right for
Type2 Diabetes Mellitus
Handok Inc. 168
Early research (Phase 1)Study completedNCT02183311
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 1356 BS in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 56
Large-scale testing (Phase 3)Study completedNCT01084005
What this trial is testing

Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 241
Large-scale testing (Phase 3)Study completedNCT00915772
What this trial is testing

Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 567
Early research (Phase 1)Study completedNCT06932159
What this trial is testing

Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated Tablets

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Humanis Saglık Anonim Sirketi 40
Early research (Phase 1)Study completedNCT02212782
What this trial is testing

The Pharmacokinetic Profiles of Linagliptin With DW1029M

Who this might be right for
Healthy
Dong Wha Pharmaceutical Co. Ltd. 12
Early research (Phase 1)Study completedNCT03609294
What this trial is testing

A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy Volunteers

Who this might be right for
HypertensionDiabetes
Boryung Pharmaceutical Co., Ltd 67
Large-scale testing (Phase 3)Study completedNCT01243424
What this trial is testing

CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 6,103
Early research (Phase 1)Study completedNCT02183298
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 36
Large-scale testing (Phase 3)Study completedNCT02015299
What this trial is testing

Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
dr. DJ Mulder 45
Large-scale testing (Phase 3)Study completedNCT02851745
What this trial is testing

Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry

Who this might be right for
Diabetes Mellitus, Type 2Left Ventricular Systolic Dysfunction
Heart Care Foundation 188
Early research (Phase 1)Study completedNCT02183350
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 47
Large-scale testing (Phase 3)Study completedNCT00798161
What this trial is testing

Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 857
Post-approval studies (Phase 4)UnknownNCT01547104
What this trial is testing

Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus Type 2
Marcus Borchert 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation